Riverview Trust Company’s Tandem Diabetes Care TNDM Stock Holding History

Riverview Trust Company’s Portfolio TNDM Stock Details TNDM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-338	Closed	-$13.7K	–	750
2023 Q1	$13.7K	Hold	338	–	–	0.01%	554
2022 Q4	$15K	Buy	+338	New	+$15.3K	0.01%	450
2022 Q3	–	Sell	-216	Closed	-$13K	–	883
2022 Q2	$13K	Buy	216 +78	+57%	+$6.4K	0.01%	591
2022 Q1	$16K	Buy	+138	New	+$16.1K	0.01%	590

Other funds holding TNDM

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Eminence Capital New York $4.36B AUM 3.1% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

Riverview Trust Company's TNDM Position: Q2 2023 in Review

Riverview Trust Company sold out of Tandem Diabetes Care (TNDM) in Q2 2023, closing a stake of 338 shares — an estimated $13.7K sold.

Riverview Trust Company first reported a position in TNDM in Q1 2022 and held it in 4 quarters. The position peaked at $16K in Q1 2022. 247 funds tracked by Wall St. Rank hold TNDM as of Q2 2023.

Riverview Trust Company reported no remaining Tandem Diabetes Care position as of Q2 2023 after selling out during the quarter.
Riverview Trust Company sold 338 Tandem Diabetes Care shares in Q2 2023, an estimated $13.7K.
Riverview Trust Company first reported a position in Tandem Diabetes Care in Q1 2022 and held it in 4 quarters.
Riverview Trust Company's Tandem Diabetes Care position peaked at $16K in Q1 2022.
247 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q2 2023.

Based on Riverview Trust Company's 13F filing for Q2 2023, filed 18 Jul 2023.